Mitch C. Hill - 16 May 2022 Form 4 Insider Report for Inari Medical, Inc.

Signature
/s/ Angela Ahmad, attorney-in-fact for Mitch C. Hill
Issuer symbol
N/A
Transactions as of
16 May 2022
Net transactions value
-$440,106
Form type
4
Filing time
18 May 2022, 16:40:47 UTC
Previous filing
20 Apr 2022
Next filing
17 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $3,428 +7,500 +9.4% $0.4570* 87,062 16 May 2022 Direct F1
transaction NARI Common Stock Sale $85,574 -1,505 -1.7% $56.86 85,557 16 May 2022 Direct F1, F2
transaction NARI Common Stock Sale $75,462 -1,304 -1.5% $57.87 84,253 16 May 2022 Direct F1, F3
transaction NARI Common Stock Sale $65,208 -1,100 -1.3% $59.28 83,153 16 May 2022 Direct F1, F4
transaction NARI Common Stock Sale $134,322 -2,232 -2.7% $60.18 80,921 16 May 2022 Direct F1, F4
transaction NARI Common Stock Sale $82,967 -1,359 -1.7% $61.05 79,562 16 May 2022 Direct F1, F5
holding NARI Common Stock 1,600 16 May 2022 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Stock Options (Right to Buy) Options Exercise $0 -7,500 -3.4% $0.000000 214,477 16 May 2022 Common Stock 7,500 $0.4570 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2021
F2 This transaction was executed in multiple trades at prices ranging from $56.41 to $57.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $57.43 to $58.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $59.66 to $60.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $60.66 to $61.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 Option vested with respect to 25% of the underlying shares on April 30, 2020 and vests with respect to the remaining shares in 36 equal monthly installment thereafter.